Riociguat

ArticlesMedicine Compliance Aid StabilityNew Medicines ·
24406211000001105

Articles

Medicine Compliance Aid Stability

AdempasBayer plc

Bayer plc
Adempas
Tablets 500 microgram, 1mg, 1.5mg, 2mg, 2.5mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage.
9 November 2015

New Medicines

AdempasPulmonary hypertension; arterial (PAH) - in pts not responding to PDE5 inhibitors

Information

Adempas
Licence extension / variation
Bayer
Bayer

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Yes

Category

Guanylate cyclase stimulant - first in class
In its pure idiopathic form pulmonary hypertension is a rare disease with an approximate annual incidence of about 1–3 cases per million population.
Pulmonary hypertension; arterial (PAH) - in pts not responding to PDE5 inhibitors
Oral